Forward Pharma | Evaluate

Where is the IPO class of 2014-15 now?

A golden age for biotech flotations yielded some spectacular blow-ups, but also saw several groups reward investors with premium-priced takeovers.

January 30, 2018

Biogen burned as Forward goes backwards

Biogen might be wondering what else it could have spent $1.2bn on as Forward Pharma's patent challenge against Tecfidera falters.

January 08, 2018

Asia wins 2017’s mid-cap race

A cooling of the M&A climate allows Asia-based groups to come to the fore.

November 28, 2017

Alkermes’s Tecfidera sleeper falls asleep

September 18, 2017

Corrected: Weekly Market Movers: Global Majors & Industry (to 15 Sep 2017)

April 03, 2017

Patent rulings knock Acorda and Forward | News

April 03, 2017

Patent rulings knock Acorda and Forward

Acorda and Forward have been bashed by unfavourable US patent verdicts in multiple sclerosis, while Steadymed got a boost.

March 31, 2017

Snippet roundup: Novartis meets CAR-T filing deadline, Numab snares Ono

March 22, 2017

Court victory benefits Biogen and its Tecfidera rival alike

January 17, 2017

Biogen windfall reveals Europe's best capitalised and most mispriced biotech

November 14, 2016

Event – Biogen gears up for Tecfidera’s day in patent court

Load More